Stereotaxis, Inc. (NASDAQ:STXS)

MacroAlan (21.48) Submitted: 11/19/2007 9:42:42 AM : Start Price: $12.93 STXS Score: -93.19

Tops in their industry.

frogtoad (< 20) Submitted: 8/14/2007 11:37:47 PM : Start Price: $13.28 STXS Score: -95.25

This company has a revolutionary product that is becoming the standard of care for the treatment of a heart condition known as atrial fibrillation, which is an increasing demographic as baby-boomers age. Partnerships with big boys Siemens, Philips, and J&J provide a level of comfort and possibility for a future buyout.

ProphetOfProfits (55.01) Submitted: 7/25/2007 8:24:07 AM : Start Price: $13.25 STXS Score: -89.29

great future for this company - time to pick them again for another ride

agoodtoy (< 20) Submitted: 5/17/2007 4:18:23 PM : Start Price: $11.47 STXS Score: -89.35

Medical Device maker, leader in it's field. Stereotaxis Niobe System is a cardiology instrument control system for the interventional treatment of coronary artery disease and arrhythmias in the United States, Europe. Cath Labs are getting more and more use. Doctors and Patients want more minimally invasive treatments and shorter recovery times. Been struggling for the last 2 years but their backlog and visibilty are increasing.

crawfordt (40.75) Submitted: 4/12/2007 11:00:38 PM : Start Price: $11.56 STXS Score: -93.88

Coronary delivery system
Chart pattern is right for a move!!

edinberlin (47.55) Submitted: 3/15/2007 9:25:49 AM : Start Price: $10.71 STXS Score: -98.19

Niobe system truly a winner. Expect stock price movement ~ ISRG.

rossoyoungs (< 20) Submitted: 2/25/2007 11:17:52 PM : Start Price: $12.31 STXS Score: -93.79

Dr. jekyll, Mr. Hyde, bounces like a ball - market cap high but trend says it will win, I would buy at 10 and watch for insiders to sell at 11.50 (idiots should stop killing the upside. could go much higher in several years.

alolio (38.55) Submitted: 10/24/2006 12:09:37 AM : Start Price: $12.10 STXS Score: -100.02

The technology that Stereotaxis employs is excellent, revolutionary even, and if they can keep up with the pace of technology that they have set there is excellent potential for this company to do well. On the down side, it is a very expensive piece of capital equipment that will depend on sales of either service contracts or proprietary products to keep a revenue stream flowing. That said, there are many ways in which Stereotaxis can be partnered with other, existing technologies that will greatly expand the usefullness and longevity of its products.

Lfierz (57.98) Submitted: 10/2/2006 7:51:59 PM : Start Price: $10.37 STXS Score: -102.53

growth will start from 2007/8, then be sustained for several years

ablate (< 20) Submitted: 9/2/2006 3:15:20 AM : Start Price: $10.82 STXS Score: -104.40

Only FDA approved remote navigation system in the market that is used for complex medical procedures. It's gaining wide acceptance by top medical researchers in the field.

coveman100 (74.63) Submitted: 8/27/2006 9:20:42 PM : Start Price: $10.80 STXS Score: -105.92

think ISRG